Q&A: Could a new melanoma vaccine change cancer treatment?
A personalized melanoma vaccine, called intismeran, could mark a major advance in cancer treatment. Last week, pharmaceutical companies Merck and Moderna announced clinical trial results showing the vaccine, combined with immunotherapy, reduced the risk of cancer returning or death by 42% compared with immunotherapy alone.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Workplace ergonomics may do little to ease arm, neck or shoulder pain
Health
Medicine
-
Novel alpha radiopharmaceutical therapy shows promise in early-phase prostate cancer trial
Health
Medicine
-
Needle-free Strep A vaccine triggers local and bodywide immune responses in mice
Health
Disease & Outbreaks
-
Wearable EEG patch records stable brain signals over 24 hours, including sleep
Science
Research
-
How socioeconomic factors affect outcomes in this deadly cancer
Health
Disease & Outbreaks
United States
-
Autistic women experience more severe menopausal symptoms, study confirms
Health
Medicine
-
ADHD medication amplifies brain response to grammatically ambiguous sentences, study finds
Science
Research
Netherlands
-
Night shifts during pregnancy linked to heightened risk of young child's neurodevelopmental abnormalities
Health
Public Health